216 related articles for article (PubMed ID: 18951447)
21. Initial Results of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome.
Howarth DR; Lum SS; Esquivel P; Garberoglio CA; Senthil M; Solomon NL
Am Surg; 2015 Oct; 81(10):941-4. PubMed ID: 26463285
[TBL] [Abstract][Full Text] [Related]
22. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data.
van Marcke C; Collard A; Vikkula M; Duhoux FP
Crit Rev Oncol Hematol; 2018 Dec; 132():138-144. PubMed ID: 30447919
[TBL] [Abstract][Full Text] [Related]
24. Power of pedigree likelihood analysis in extended pedigrees to classify rare variants of uncertain significance in cancer risk genes.
Rosenthal EA; Ranola JMO; Shirts BH
Fam Cancer; 2017 Oct; 16(4):611-620. PubMed ID: 28534081
[TBL] [Abstract][Full Text] [Related]
25. A guide for functional analysis of BRCA1 variants of uncertain significance.
Millot GA; Carvalho MA; Caputo SM; Vreeswijk MP; Brown MA; Webb M; Rouleau E; Neuhausen SL; Hansen Tv; Galli A; Brandão RD; Blok MJ; Velkova A; Couch FJ; Monteiro AN;
Hum Mutat; 2012 Nov; 33(11):1526-37. PubMed ID: 22753008
[TBL] [Abstract][Full Text] [Related]
26. Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.
Goldgar DE; Easton DF; Deffenbaugh AM; Monteiro AN; Tavtigian SV; Couch FJ;
Am J Hum Genet; 2004 Oct; 75(4):535-44. PubMed ID: 15290653
[TBL] [Abstract][Full Text] [Related]
27. Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.
Solomon I; Harrington E; Hooker G; Erby L; Axilbund J; Hampel H; Semotiuk K; Blanco A; Klein WMP; Giardiello F; Leonard L
J Genet Couns; 2017 Aug; 26(4):866-877. PubMed ID: 28127677
[TBL] [Abstract][Full Text] [Related]
28. Classification and Clinical Management of Variants of Uncertain Significance in High Penetrance Cancer Predisposition Genes.
Moghadasi S; Eccles DM; Devilee P; Vreeswijk MP; van Asperen CJ
Hum Mutat; 2016 Apr; 37(4):331-6. PubMed ID: 26777316
[TBL] [Abstract][Full Text] [Related]
29. The functional impact of variants of uncertain significance in BRCA2.
Mesman RLS; Calléja FMGR; Hendriks G; Morolli B; Misovic B; Devilee P; van Asperen CJ; Vrieling H; Vreeswijk MPG
Genet Med; 2019 Feb; 21(2):293-302. PubMed ID: 29988080
[TBL] [Abstract][Full Text] [Related]
30. Determining the functional significance of mismatch repair gene missense variants using biochemical and cellular assays.
Heinen CD; Juel Rasmussen L
Hered Cancer Clin Pract; 2012 Jul; 10(1):9. PubMed ID: 22824075
[TBL] [Abstract][Full Text] [Related]
31. Invasive breast carcinomas with ATM gene variants of uncertain significance share distinct histopathologic features.
Abdulrahman AA; Heintzelman RC; Corbman M; Garcia FU
Breast J; 2018 May; 24(3):291-297. PubMed ID: 28986972
[TBL] [Abstract][Full Text] [Related]
32. Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers.
Federici G; Soddu S
J Exp Clin Cancer Res; 2020 Mar; 39(1):46. PubMed ID: 32127026
[TBL] [Abstract][Full Text] [Related]
33. Assessment of functional effects of unclassified genetic variants.
Couch FJ; Rasmussen LJ; Hofstra R; Monteiro AN; Greenblatt MS; de Wind N;
Hum Mutat; 2008 Nov; 29(11):1314-26. PubMed ID: 18951449
[TBL] [Abstract][Full Text] [Related]
34. Genetic evidence and integration of various data sources for classifying uncertain variants into a single model.
Goldgar DE; Easton DF; Byrnes GB; Spurdle AB; Iversen ES; Greenblatt MS;
Hum Mutat; 2008 Nov; 29(11):1265-72. PubMed ID: 18951437
[TBL] [Abstract][Full Text] [Related]
35. An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance.
Iversen ES; Lipton G; Hart SN; Lee KY; Hu C; Polley EC; Pesaran T; Yussuf A; LaDuca H; Chao E; Karam R; Goldgar DE; Couch FJ; Monteiro ANA
NPJ Genom Med; 2022 Jun; 7(1):35. PubMed ID: 35665744
[TBL] [Abstract][Full Text] [Related]
36. Family Studies for Classification of Variants of Uncertain Classification: Current Laboratory Clinical Practice and a New Web-Based Educational Tool.
Garrett LT; Hickman N; Jacobson A; Bennett RL; Amendola LM; Rosenthal EA; Shirts BH
J Genet Couns; 2016 Dec; 25(6):1146-1156. PubMed ID: 27422780
[TBL] [Abstract][Full Text] [Related]
37. Factors predicting reclassification of variants of unknown significance.
Wright M; Menon V; Taylor L; Shashidharan M; Westercamp T; Ternent CA
Am J Surg; 2018 Dec; 216(6):1148-1154. PubMed ID: 30217367
[TBL] [Abstract][Full Text] [Related]
38. Management of Patients with a Genetic Variant of Unknown Significance.
Mahon SM
Oncol Nurs Forum; 2015 May; 42(3):316-8. PubMed ID: 25901385
[TBL] [Abstract][Full Text] [Related]
39. A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders.
Karbassi I; Maston GA; Love A; DiVincenzo C; Braastad CD; Elzinga CD; Bright AR; Previte D; Zhang K; Rowland CM; McCarthy M; Lapierre JL; Dubois F; Medeiros KA; Batish SD; Jones J; Liaquat K; Hoffman CA; Jaremko M; Wang Z; Sun W; Buller-Burckle A; Strom CM; Keiles SB; Higgins JJ
Hum Mutat; 2016 Jan; 37(1):127-34. PubMed ID: 26467025
[TBL] [Abstract][Full Text] [Related]
40. Physician interpretation of variants of uncertain significance.
Macklin SK; Jackson JL; Atwal PS; Hines SL
Fam Cancer; 2019 Jan; 18(1):121-126. PubMed ID: 29721668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
